EGFR Inhibitor Market, Global Outlook and Forecast 2023-2029

Report ID: MMG300327 | Category: Pharma & Healthcare | Pages: 74 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global EGFR Inhibitor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
First Generation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of EGFR Inhibitor include AstraZeneca, Roche, Boehringer-Ingelheim, Pfizer, Mylan, Genvio Pharma, Alice, Teva Pharmaceuticals and Blueprint Medicines, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for EGFR Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR Inhibitor. This report contains market size and forecasts of EGFR Inhibitor in global, including the following market information:
Global EGFR Inhibitor Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global EGFR Inhibitor Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five EGFR Inhibitor companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the EGFR Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global EGFR Inhibitor Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global EGFR Inhibitor Market Segment Percentages, by Type, 2022 (%)
    First Generation
    Second Generation
    Three Generations
    Four Generations
Global EGFR Inhibitor Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global EGFR Inhibitor Market Segment Percentages, by Application, 2022 (%)
    Healthcare
    Experimental Use
    Other
Global EGFR Inhibitor Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global EGFR Inhibitor Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies EGFR Inhibitor revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies EGFR Inhibitor revenues share in global market, 2022 (%)
Key companies EGFR Inhibitor sales in global market, 2018-2023 (Estimated), (K Units)
Key companies EGFR Inhibitor sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    AstraZeneca
    Roche
    Boehringer-Ingelheim
    Pfizer
    Mylan
    Genvio Pharma
    Alice
    Teva Pharmaceuticals
    Blueprint Medicines
    Biotherapeutics
    Junshi Biosciences
    Cttq
    Betta Pharmaceuticals
    Qilu Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of EGFR Inhibitor, market overview.
Chapter 2: Global EGFR Inhibitor market size in revenue and volume.
Chapter 3: Detailed analysis of EGFR Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of EGFR Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global EGFR Inhibitor capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 EGFR Inhibitor Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global EGFR Inhibitor Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global EGFR Inhibitor Overall Market Size
    2.1 Global EGFR Inhibitor Market Size: 2022 VS 2029
    2.2 Global EGFR Inhibitor Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global EGFR Inhibitor Sales: 2018-2029
3 Company Landscape
    3.1 Top EGFR Inhibitor Players in Global Market
    3.2 Top Global EGFR Inhibitor Companies Ranked by Revenue
    3.3 Global EGFR Inhibitor Revenue by Companies
    3.4 Global EGFR Inhibitor Sales by Companies
    3.5 Global EGFR Inhibitor Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 EGFR Inhibitor Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers EGFR Inhibitor Product Type
    3.8 Tier 1, Tier 2 and Tier 3 EGFR Inhibitor Players in Global Market
        3.8.1 List of Global Tier 1 EGFR Inhibitor Companies
        3.8.2 List of Global Tier 2 and Tier 3 EGFR Inhibitor Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global EGFR Inhibitor Market Size Markets, 2022 & 2029
        4.1.2 First Generation
        4.1.3 Second Generation
        4.1.4 Three Generations
        4.1.5 Four Generations
    4.2 By Type - Global EGFR Inhibitor Revenue & Forecasts
        4.2.1 By Type - Global EGFR Inhibitor Revenue, 2018-2023
        4.2.2 By Type - Global EGFR Inhibitor Revenue, 2024-2029
        4.2.3 By Type - Global EGFR Inhibitor Revenue Market Share, 2018-2029
    4.3 By Type - Global EGFR Inhibitor Sales & Forecasts
        4.3.1 By Type - Global EGFR Inhibitor Sales, 2018-2023
        4.3.2 By Type - Global EGFR Inhibitor Sales, 2024-2029
        4.3.3 By Type - Global EGFR Inhibitor Sales Market Share, 2018-2029
    4.4 By Type - Global EGFR Inhibitor Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global EGFR Inhibitor Market Size, 2022 & 2029
        5.1.2 Healthcare
        5.1.3 Experimental Use
        5.1.4 Other
    5.2 By Application - Global EGFR Inhibitor Revenue & Forecasts
        5.2.1 By Application - Global EGFR Inhibitor Revenue, 2018-2023
        5.2.2 By Application - Global EGFR Inhibitor Revenue, 2024-2029
        5.2.3 By Application - Global EGFR Inhibitor Revenue Market Share, 2018-2029
    5.3 By Application - Global EGFR Inhibitor Sales & Forecasts
        5.3.1 By Application - Global EGFR Inhibitor Sales, 2018-2023
        5.3.2 By Application - Global EGFR Inhibitor Sales, 2024-2029
        5.3.3 By Application - Global EGFR Inhibitor Sales Market Share, 2018-2029
    5.4 By Application - Global EGFR Inhibitor Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global EGFR Inhibitor Market Size, 2022 & 2029
    6.2 By Region - Global EGFR Inhibitor Revenue & Forecasts
        6.2.1 By Region - Global EGFR Inhibitor Revenue, 2018-2023
        6.2.2 By Region - Global EGFR Inhibitor Revenue, 2024-2029
        6.2.3 By Region - Global EGFR Inhibitor Revenue Market Share, 2018-2029
    6.3 By Region - Global EGFR Inhibitor Sales & Forecasts
        6.3.1 By Region - Global EGFR Inhibitor Sales, 2018-2023
        6.3.2 By Region - Global EGFR Inhibitor Sales, 2024-2029
        6.3.3 By Region - Global EGFR Inhibitor Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America EGFR Inhibitor Revenue, 2018-2029
        6.4.2 By Country - North America EGFR Inhibitor Sales, 2018-2029
        6.4.3 US EGFR Inhibitor Market Size, 2018-2029
        6.4.4 Canada EGFR Inhibitor Market Size, 2018-2029
        6.4.5 Mexico EGFR Inhibitor Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe EGFR Inhibitor Revenue, 2018-2029
        6.5.2 By Country - Europe EGFR Inhibitor Sales, 2018-2029
        6.5.3 Germany EGFR Inhibitor Market Size, 2018-2029
        6.5.4 France EGFR Inhibitor Market Size, 2018-2029
        6.5.5 U.K. EGFR Inhibitor Market Size, 2018-2029
        6.5.6 Italy EGFR Inhibitor Market Size, 2018-2029
        6.5.7 Russia EGFR Inhibitor Market Size, 2018-2029
        6.5.8 Nordic Countries EGFR Inhibitor Market Size, 2018-2029
        6.5.9 Benelux EGFR Inhibitor Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia EGFR Inhibitor Revenue, 2018-2029
        6.6.2 By Region - Asia EGFR Inhibitor Sales, 2018-2029
        6.6.3 China EGFR Inhibitor Market Size, 2018-2029
        6.6.4 Japan EGFR Inhibitor Market Size, 2018-2029
        6.6.5 South Korea EGFR Inhibitor Market Size, 2018-2029
        6.6.6 Southeast Asia EGFR Inhibitor Market Size, 2018-2029
        6.6.7 India EGFR Inhibitor Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America EGFR Inhibitor Revenue, 2018-2029
        6.7.2 By Country - South America EGFR Inhibitor Sales, 2018-2029
        6.7.3 Brazil EGFR Inhibitor Market Size, 2018-2029
        6.7.4 Argentina EGFR Inhibitor Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa EGFR Inhibitor Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa EGFR Inhibitor Sales, 2018-2029
        6.8.3 Turkey EGFR Inhibitor Market Size, 2018-2029
        6.8.4 Israel EGFR Inhibitor Market Size, 2018-2029
        6.8.5 Saudi Arabia EGFR Inhibitor Market Size, 2018-2029
        6.8.6 UAE EGFR Inhibitor Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Company Summary
        7.1.2 AstraZeneca Business Overview
        7.1.3 AstraZeneca EGFR Inhibitor Major Product Offerings
        7.1.4 AstraZeneca EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.1.5 AstraZeneca Key News & Latest Developments
    7.2 Roche
        7.2.1 Roche Company Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche EGFR Inhibitor Major Product Offerings
        7.2.4 Roche EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.2.5 Roche Key News & Latest Developments
    7.3 Boehringer-Ingelheim
        7.3.1 Boehringer-Ingelheim Company Summary
        7.3.2 Boehringer-Ingelheim Business Overview
        7.3.3 Boehringer-Ingelheim EGFR Inhibitor Major Product Offerings
        7.3.4 Boehringer-Ingelheim EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.3.5 Boehringer-Ingelheim Key News & Latest Developments
    7.4 Pfizer
        7.4.1 Pfizer Company Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer EGFR Inhibitor Major Product Offerings
        7.4.4 Pfizer EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.4.5 Pfizer Key News & Latest Developments
    7.5 Mylan
        7.5.1 Mylan Company Summary
        7.5.2 Mylan Business Overview
        7.5.3 Mylan EGFR Inhibitor Major Product Offerings
        7.5.4 Mylan EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.5.5 Mylan Key News & Latest Developments
    7.6 Genvio Pharma
        7.6.1 Genvio Pharma Company Summary
        7.6.2 Genvio Pharma Business Overview
        7.6.3 Genvio Pharma EGFR Inhibitor Major Product Offerings
        7.6.4 Genvio Pharma EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.6.5 Genvio Pharma Key News & Latest Developments
    7.7 Alice
        7.7.1 Alice Company Summary
        7.7.2 Alice Business Overview
        7.7.3 Alice EGFR Inhibitor Major Product Offerings
        7.7.4 Alice EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.7.5 Alice Key News & Latest Developments
    7.8 Teva Pharmaceuticals
        7.8.1 Teva Pharmaceuticals Company Summary
        7.8.2 Teva Pharmaceuticals Business Overview
        7.8.3 Teva Pharmaceuticals EGFR Inhibitor Major Product Offerings
        7.8.4 Teva Pharmaceuticals EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.8.5 Teva Pharmaceuticals Key News & Latest Developments
    7.9 Blueprint Medicines
        7.9.1 Blueprint Medicines Company Summary
        7.9.2 Blueprint Medicines Business Overview
        7.9.3 Blueprint Medicines EGFR Inhibitor Major Product Offerings
        7.9.4 Blueprint Medicines EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.9.5 Blueprint Medicines Key News & Latest Developments
    7.10 Biotherapeutics
        7.10.1 Biotherapeutics Company Summary
        7.10.2 Biotherapeutics Business Overview
        7.10.3 Biotherapeutics EGFR Inhibitor Major Product Offerings
        7.10.4 Biotherapeutics EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.10.5 Biotherapeutics Key News & Latest Developments
    7.11 Junshi Biosciences
        7.11.1 Junshi Biosciences Company Summary
        7.11.2 Junshi Biosciences EGFR Inhibitor Business Overview
        7.11.3 Junshi Biosciences EGFR Inhibitor Major Product Offerings
        7.11.4 Junshi Biosciences EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.11.5 Junshi Biosciences Key News & Latest Developments
    7.12 Cttq
        7.12.1 Cttq Company Summary
        7.12.2 Cttq EGFR Inhibitor Business Overview
        7.12.3 Cttq EGFR Inhibitor Major Product Offerings
        7.12.4 Cttq EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.12.5 Cttq Key News & Latest Developments
    7.13 Betta Pharmaceuticals
        7.13.1 Betta Pharmaceuticals Company Summary
        7.13.2 Betta Pharmaceuticals EGFR Inhibitor Business Overview
        7.13.3 Betta Pharmaceuticals EGFR Inhibitor Major Product Offerings
        7.13.4 Betta Pharmaceuticals EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.13.5 Betta Pharmaceuticals Key News & Latest Developments
    7.14 Qilu Pharmaceutical
        7.14.1 Qilu Pharmaceutical Company Summary
        7.14.2 Qilu Pharmaceutical Business Overview
        7.14.3 Qilu Pharmaceutical EGFR Inhibitor Major Product Offerings
        7.14.4 Qilu Pharmaceutical EGFR Inhibitor Sales and Revenue in Global (2018-2023)
        7.14.5 Qilu Pharmaceutical Key News & Latest Developments
8 Global EGFR Inhibitor Production Capacity, Analysis
    8.1 Global EGFR Inhibitor Production Capacity, 2018-2029
    8.2 EGFR Inhibitor Production Capacity of Key Manufacturers in Global Market
    8.3 Global EGFR Inhibitor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 EGFR Inhibitor Supply Chain Analysis
    10.1 EGFR Inhibitor Industry Value Chain
    10.2 EGFR Inhibitor Upstream Market
    10.3 EGFR Inhibitor Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 EGFR Inhibitor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

EGFR Inhibitor Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?